CureVac and GSK Collaboration and License Agreement

• Post author:GHIAA Editor
• Post published:September 15, 2021
• Post category:

Continue ReadingCureVac and GSK Collaboration and License Agreement

CEPI – Valneva, Chikungunya Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 23, 2021
• Post category:

Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement

NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

BMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingBMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingCEPI – CureVac, Framework Partnering Agreement

US Department of Defense – Moderna, COVID-19 Vaccine Supply Agreement

• Post author:GHIAA Admin
• Post published:January 19, 2021
• Post category:

Continue ReadingUS Department of Defense – Moderna, COVID-19 Vaccine Supply Agreement

BARDA – Moderna, COVID-19 Vaccine Development Agreement

• Post author:GHIAA Admin
• Post published:January 19, 2021
• Post category:

Continue ReadingBARDA – Moderna, COVID-19 Vaccine Development Agreement

Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement

• Post author:GHIAA Admin
• Post published:December 14, 2020
• Post category:

Continue ReadingSanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement

Gates Foundation Sample Grant Terms & Conditions

• Post author:Loren
• Post published:May 30, 2020
• Post category:

Continue ReadingGates Foundation Sample Grant Terms & Conditions